Novavax, Inc. (LON:0A3S)
London · Delayed Price · Currency is GBP · Price in USD 8.00
-0.27 (-3.21%)
At close: Feb 5, 2026
Novavax Market Cap
Novavax has a market cap or net worth of 944.57 million as of February 6, 2026. Its market cap has decreased by -17.75% in one year.
Market Cap
944.57M
Enterprise Value
566.59M
Revenue
792.04M
Ranking
n/a
PE Ratio
3.72
Stock Price
8.00
Market Cap Chart
Since July 25, 1996, Novavax's market cap has increased from 22.60M to 944.57M, an increase of 4,079.55%. That is a compound annual growth rate of 13.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 944.57M | 16.42% |
| Dec 31, 2025 | 811.35M | -21.13% |
| Dec 31, 2024 | 1.03B | 129.81% |
| Dec 29, 2023 | 447.65M | -38.98% |
| Dec 30, 2022 | 733.56M | -90.82% |
| Dec 31, 2021 | 7.99B | 167.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Supermarket Income REIT | 1.05B |
| FirstGroup | 1.03B |
| Jupiter Fund Management | 1.03B |
| Oxford Biomedica | 1.00B |
| Kier Group | 998.64M |
| Kainos Group | 997.63M |
| Senior | 985.86M |
| Dar Global | 976.04M |